Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herceptin +/- Taxane in Relapsed HER2+ MBC
NCT00475670Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2005
- Primary completion
- Jun 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 15
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by Roche. Started Oct 2005; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00475670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475670.